Programa de Negociación de Precios de Medicamentos de Medicare para: Una Nueva Era en los Costos de Medicamentos
The Medicare drug price negotiation Program for 2026 is a transformative initiative designed to lower prescription drug costs for millions of Americans. By allowing Medicare to negotiate directly with pharmaceutical companies, this program aims to alleviate financial burdens and improve access to essential medications.